The page lists 5 deliverables related to the research project "BetaCellTherapy".
title and desprition | type | last update |
---|---|---|
Human beta cell grafts with QC data for start transplants in subgroup of type 1 diabetes recipients of VCTM implantTo be delivered to WP4 for treatment of patient cohort that ended VCTM-01 trial under immune therapy Programme: H2020-EU.3.1.3. - Topic(s): PHC-15-2015 |
Demonstrators, pilots, prototypes | 2020-03-11 |
Human beta cell preparations with QC data for comparative assessment of human iPS-derived implants in preclinical model and their use in screening assayTo be delivered to WP6-9 for interpretation outcome human iPS-derived implants, and to WP6 for screening assay Programme: H2020-EU.3.1.3. - Topic(s): PHC-15-2015 |
Demonstrators, pilots, prototypes | 2020-03-11 |
Production of biodegradable microparticles for local release of VEGF, NGF and exenatideIn vitro kinetics and in vivo compatibility should be determined in mice Programme: H2020-EU.3.1.3. - Topic(s): PHC-15-2015 |
Demonstrators, pilots, prototypes | 2019-09-13 |
Time-table for public information on programSee milestone Programme: H2020-EU.3.1.3. - Topic(s): PHC-15-2015 |
Other | 2019-09-13 |
Communication network operationalSee 3.2 and 3.3 Part B Programme: H2020-EU.3.1.3. - Topic(s): PHC-15-2015 |
Other | 2019-09-13 |